Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy

Abstract Background This study aims to investigate factors and prognosis of neovascular glaucoma (NVG) after pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy (PDR). Methods A total of 200 PDR patients with 225 eyes from May 2017 to January 2023 were retrospectively ana...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaolu Cao, Peipei Jia, Xiulian Qiao, Beibei Gao, Fuyin wang
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-025-03984-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850208336058777600
author Xiaolu Cao
Peipei Jia
Xiulian Qiao
Beibei Gao
Fuyin wang
author_facet Xiaolu Cao
Peipei Jia
Xiulian Qiao
Beibei Gao
Fuyin wang
author_sort Xiaolu Cao
collection DOAJ
description Abstract Background This study aims to investigate factors and prognosis of neovascular glaucoma (NVG) after pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy (PDR). Methods A total of 200 PDR patients with 225 eyes from May 2017 to January 2023 were retrospectively analyzed, including 115 males (128 eyes) and 85 females (97 eyes) with ages ranging from 30 to 75 years. All 25G PPV surgeries were completed by the same experienced chief physician. During the surgery, the anterior retinal fibrous vascular membrane was fully removed, and laser panretinal photocoagulation (PRP) was performed, phacoemulsification was combined in 114 patients. The average postoperative follow-up time was 10.65 ± 6.84 months and occurrence of NVG was recorded. Potential risk factors of NVG included age, glycated hemoglobin (HbAlc), blood urea nitrogen (BUN), severity of preoperative fundus lesion, preoperative treatment of anti-vascular endothelial growth factor (VEGF), preoperative PRP application, combination of phacoemulsification. Results Among the total 225 eyes, 15 (6.7%) eyes developed NVG 1–12 months after surgery, including 11 cases within 6 months. Incidence of NVG was associated with age (t=-3.974), preoperative treatment of anti-VEGF (χ2 = 5.706), preoperative PRP application (χ2 = 4.744), comorbid tractional retinal detachment (TRD) (χ2 = 3.883), comorbid fibrovascular proliferation (FVP) (χ2 = 4.093), and combination of phacoemulsification (χ2 = 6.179), with all P values less than 0.05. On the other hand, no differences were found in HbAlc (t = 0.733) and BUN (t = 0.470), with both P values greater than 0.05. By the end of follow-up, all NVG cases after PPV underwent intravitreal injection of anti-VRGF drugs and supplementary retinal laser therapy, of which 8 patients had stable intraocular pressure control, 5 patients received drainage valve implantation surgery to control intraocular pressure, 1 patient abandoned surgery due to no light perception at presentation, and 1 patient underwent cyclophotocoagulation. The postoperative best corrected visual acuity (BCVA) after NVG was statistically significant compared with that before NVG (P < 0.05). Conclusions Occurrence of NVG in PDR was related to preoperative PRP and anti-VEGF, and might further have impact on prognosis. In addition, comprehensive consideration of patient’s age, severity of preoperative fundus lesion and appropriate surgical method (i.e., whether combined with phacoemulsification) could be protective factors of NVG. Trial registration ClinicalTrials.gov, NCT02399887, Registered 25 March 2019.
format Article
id doaj-art-c8a0199bedce41508e4ed4a28c628bc2
institution OA Journals
issn 1471-2415
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj-art-c8a0199bedce41508e4ed4a28c628bc22025-08-20T02:10:16ZengBMCBMC Ophthalmology1471-24152025-03-012511510.1186/s12886-025-03984-2Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathyXiaolu Cao0Peipei Jia1Xiulian Qiao2Beibei Gao3Fuyin wang4Hebei Ophthalmology Key lab, Hebei Eye HospitalHebei Ophthalmology Key lab, Hebei Eye HospitalHebei Ophthalmology Key lab, Hebei Eye HospitalHebei Ophthalmology Key lab, Hebei Eye HospitalHebei Ophthalmology Key lab, Hebei Eye HospitalAbstract Background This study aims to investigate factors and prognosis of neovascular glaucoma (NVG) after pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy (PDR). Methods A total of 200 PDR patients with 225 eyes from May 2017 to January 2023 were retrospectively analyzed, including 115 males (128 eyes) and 85 females (97 eyes) with ages ranging from 30 to 75 years. All 25G PPV surgeries were completed by the same experienced chief physician. During the surgery, the anterior retinal fibrous vascular membrane was fully removed, and laser panretinal photocoagulation (PRP) was performed, phacoemulsification was combined in 114 patients. The average postoperative follow-up time was 10.65 ± 6.84 months and occurrence of NVG was recorded. Potential risk factors of NVG included age, glycated hemoglobin (HbAlc), blood urea nitrogen (BUN), severity of preoperative fundus lesion, preoperative treatment of anti-vascular endothelial growth factor (VEGF), preoperative PRP application, combination of phacoemulsification. Results Among the total 225 eyes, 15 (6.7%) eyes developed NVG 1–12 months after surgery, including 11 cases within 6 months. Incidence of NVG was associated with age (t=-3.974), preoperative treatment of anti-VEGF (χ2 = 5.706), preoperative PRP application (χ2 = 4.744), comorbid tractional retinal detachment (TRD) (χ2 = 3.883), comorbid fibrovascular proliferation (FVP) (χ2 = 4.093), and combination of phacoemulsification (χ2 = 6.179), with all P values less than 0.05. On the other hand, no differences were found in HbAlc (t = 0.733) and BUN (t = 0.470), with both P values greater than 0.05. By the end of follow-up, all NVG cases after PPV underwent intravitreal injection of anti-VRGF drugs and supplementary retinal laser therapy, of which 8 patients had stable intraocular pressure control, 5 patients received drainage valve implantation surgery to control intraocular pressure, 1 patient abandoned surgery due to no light perception at presentation, and 1 patient underwent cyclophotocoagulation. The postoperative best corrected visual acuity (BCVA) after NVG was statistically significant compared with that before NVG (P < 0.05). Conclusions Occurrence of NVG in PDR was related to preoperative PRP and anti-VEGF, and might further have impact on prognosis. In addition, comprehensive consideration of patient’s age, severity of preoperative fundus lesion and appropriate surgical method (i.e., whether combined with phacoemulsification) could be protective factors of NVG. Trial registration ClinicalTrials.gov, NCT02399887, Registered 25 March 2019.https://doi.org/10.1186/s12886-025-03984-2Proliferative diabetic retinopathyPars plana vitrectomyNeovascular glaucoma
spellingShingle Xiaolu Cao
Peipei Jia
Xiulian Qiao
Beibei Gao
Fuyin wang
Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
BMC Ophthalmology
Proliferative diabetic retinopathy
Pars plana vitrectomy
Neovascular glaucoma
title Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
title_full Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
title_fullStr Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
title_full_unstemmed Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
title_short Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
title_sort causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy
topic Proliferative diabetic retinopathy
Pars plana vitrectomy
Neovascular glaucoma
url https://doi.org/10.1186/s12886-025-03984-2
work_keys_str_mv AT xiaolucao causesandprognosisofneovascularglaucomaafterparsplanavitrectomyinpatientswithdiabeticretinopathy
AT peipeijia causesandprognosisofneovascularglaucomaafterparsplanavitrectomyinpatientswithdiabeticretinopathy
AT xiulianqiao causesandprognosisofneovascularglaucomaafterparsplanavitrectomyinpatientswithdiabeticretinopathy
AT beibeigao causesandprognosisofneovascularglaucomaafterparsplanavitrectomyinpatientswithdiabeticretinopathy
AT fuyinwang causesandprognosisofneovascularglaucomaafterparsplanavitrectomyinpatientswithdiabeticretinopathy